Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Sort ascending Bone Marrow Disease
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment Turkish Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Where There's Smoke, There's Fire: Inflammation Drives MDS Trends in immunology Myelodysplastic Syndromes (MDS)
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia. Transplantation and Cellular Therapy Aplastic Anemia
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia Transplantation and Cellular Therapy Aplastic Anemia, Graft Versus Host Disease (GVHD)
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide Transplantation and Cellular Therapy Aplastic Anemia
Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia Transplant Cell Therapy Aplastic Anemia
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.